{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The drug industry's image problems are beginning to hurt pharmaceutical companies where it matters most -- at the bottom line. A year after Merck's withdrawal of its arthritis medicine Vioxx led to an industrywide credibility crisis, the Food and Drug Administration is blocking new medicines that might previously have passed muster. Doctors are writing fewer prescriptions for antidepressants and other drugs whose safety has been challenged, like hormone replacement therapies for women in menopause.", "headline": {"main": "BIG DRUG MAKERS SEE SALES ERODE WITH THEIR IMAGE"}, "abstract": "Major American drug makers remain highly profitable, but sales are stagnant and profits are falling, leading to layoffs and cuts in research budgets; Food and Drug Adm is blocking new medicines that might previously have passed muster, year after Merck's withdrawal of its arthritis medicine Vioxx led to industrywide credibility crisis; doctors are writing fewer prescriptions for drugs whose safety has been challenged, and insurers and some states are taking advantage of backlash against industry to try shifting patients to older, generic drugs; overall, prescriptions continue to rise slightly, but increasing share now go to generics; American consumers seem less responsive to aggressive drug marketing, and recent poll showed only 9 percent of them believe drug companies are generally honest; in some cases companies are victims of their own success: their drugs work well enough to discourage FDA from approving new drugs if there are significant side effects; chart (M)", "print_page": "1", "word_count": 1514, "_id": "4fd287358eb7c8105d858a5e", "snippet": "The major drug makers remain highly profitable, but at some, sales are stagnant and profits are falling, leading to layoffs and cuts in research budgets.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/14/business/14pharma.html", "multimedia": [{"credit": "As pressures mount on the major pharmaceutical companies and their brands, 6 of the top 10 most-prescribed medications are now generic drugs.", "url": "imagepages/2005/11/14/business/20051114pharma_graphic.html", "rank": "1", "height": 325, "caption": "Fading Brands", "legacy": {"MultimediaPopupHeight1": "325", "MultimediaType1": "Image", "MultimediaPopupWidth1": "250", "MultimediaUrl1": "imagepages/2005/11/14/business/20051114pharma_graphic.html", "MultimediaSummary1": "As pressures mount on the major pharmaceutical companies and their brands, 6 of the top 10 most-prescribed medications are now generic drugs.", "MultimediaHeadline1": "Fading Brands"}, "type": "Image", "width": 250}], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "MERCK & COMPANY INCORPORATED"}, {"name": "organizations", "value": "PFIZER INCORPORATED"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "LABOR"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "PUBLIC OPINION"}, {"name": "subject", "value": "ADVERTISING AND MARKETING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "INDUSTRY PROFILES"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAYOFFS AND JOB REDUCTIONS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Alex", "rank": 1, "lastname": "BERENSON"}], "original": "By ALEX BERENSON"}, "document_type": "article", "pub_date": "2005-11-14T00:00:00Z", "section_name": "Front Page; Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Enrollment in the new Medicare drug benefit begins in three days, but even with President Bush hailing the plan on Saturday as ''the greatest advance in health care for seniors'' in 40 years, large numbers of older Americans appear to be overwhelmed and confused by the choices they will have to make. ''I have a Ph.D., and it's too complicated to suit me,'' said William Q. Beard, 73, a retired chemist in Wichita, Kan., who takes eight prescription drugs, including several heart medicines. ''I wonder how the vast majority of beneficiaries will handle this. I fervently wish that members of Congress had to deal with the same health care program we do.''", "headline": {"main": "CONFUSION IS RIFE ABOUT DRUG PLAN AS SIGN-UP NEARS"}, "abstract": null, "print_page": "1", "word_count": 1460, "_id": "4fd24e218eb7c8105d7ef5bd", "snippet": "Even with President Bush hailing the new Medicare drug benefits, large numbers of older Americans appear to be confused by the choices they will have to make.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/13/national/13drug.html", "multimedia": [{"url": "images/2005/11/13/national/13drugs.75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2005/11/13/national/13drugs.75.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Robert", "rank": 1, "lastname": "PEAR"}], "original": "By ROBERT PEAR; Carolyn Marshall contributed reporting from Santa Rosa, Calif., for this article, and Albert Salvato from Urbana, Ohio"}, "document_type": "article", "pub_date": "2005-11-13T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "Registration for Medicare's new prescription drug benefit starts next week. Soon millions of Americans will learn that doughnuts are bad for your health. And if we're lucky, Americans will also learn a bigger lesson: politicians who don't believe in a positive role for government shouldn't be allowed to design new government programs. Before we turn to the larger issue, let's look at how the Medicare drug benefit will work over the course of next year.", "headline": {"main": "The Deadly Doughnut", "kicker": "Op-Ed Columnist"}, "abstract": "Paul Krugman Op-Ed column notes registration for Medicare's new prescription drug benefit starts next week; offers detailed explanation of how costly it will be for those least able to pay for their medications; says Republican Congressional leaders who rammed bill through in 2003 were not trying to protect retired Americans against risk of high drug expenses, they just wanted to say that Pres Bush honored his 2000 campaign pledge to provide prescription drug coverage by passing drug bill, any drug bill; says drug bill can be fixed, but not by 'current management' (M)", "print_page": "23", "word_count": 749, "_id": "4fd24e218eb7c8105d7ef538", "snippet": "Politicians who don't believe in a positive role for government shouldn't be allowed to design new government programs.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/11/opinion/11krugman.html", "multimedia": [{"url": "imagepages/2005/09/13/timesselect/tskrugman.1.html", "rank": "1", "height": 325, "width": 250, "legacy": {"MultimediaPopupWidth1": "250", "MultimediaPopupHeight1": "325", "MultimediaUrl1": "imagepages/2005/09/13/timesselect/tskrugman.1.html", "MultimediaType1": "Image"}, "type": "Image"}, {"url": "images/2005/09/13/timesselect/tskrugman.75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2005/09/13/timesselect/tskrugman.75.jpg"}, "type": "image", "height": 75}, {"subtype": "tiny_thumb", "url": "images/2005/09/13/timesselect/tskrugman.jpg", "height": 197, "width": 184, "legacy": {"tinythumbwidth": 184, "tinythumbheight": 197, "tinythumb": "images/2005/09/13/timesselect/tskrugman.jpg", "hastinythumb": "Y"}, "type": "image"}], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "PRESIDENTIAL ELECTION OF 2000"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Paul", "lastname": "KRUGMAN"}], "original": "By PAUL KRUGMAN"}, "document_type": "article", "pub_date": "2005-11-11T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Health&Fitness", "lead_paragraph": "A new drug for acne, Aczone, was approved in July, but with a catch. The Food and Drug Administration said it would require that patients first be tested for an enzyme deficiency that could put them at risk of developing anemia from the drug. The age of personalized medicine is on the way. Increasingly, experts say, therapies will be tailored for patients based on their genetic makeup or other medical measurements. That will allow people to obtain drugs that would work best for them and avoid serious side effects.", "headline": {"main": "A Special Drug Just for You, At the End of a Long Pipelin"}, "abstract": null, "print_page": "1", "word_count": 2265, "_id": "4fd2a9fc8eb7c8105d895582", "snippet": "A new drug for acne, Aczone, was approved in July, but with a catch. The Food and Drug Administration said it would require that patients first be tested for an enzyme deficiency that could put them at risk of developing anemia from the drug.     ...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9C03E6D7143EF93BA35752C1A9639C8B63", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2005-11-08T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 4, "offset": 0, "time": 128}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}